Emphysematous Pyelonephritis (EPN) - Comprehensive Clinical Analysis

Non-contrast CT demonstrating pathognomonic gas collections within the renal parenchyma extending into the perinephric space - identical to this patient's presentation

PART 1 - Diagnosis and Differential Diagnoses (3 Marks)

Most Likely Diagnosis

Four Important Differential Diagnoses

PART 2 - Assessment and Immediate Stabilisation in the First Hour (4 Marks)

A - Airway and Breathing

• Assess GCS; with progressive drowsiness, protect airway if GCS falls below 8
• High-flow O2 to maintain SpO2 >94%
• ABG: assess lactate, pH, pCO2 (metabolic acidosis expected)

B - Haemodynamic Resuscitation

• Two large-bore IV cannulae; begin crystalloid bolus 30 mL/kg IV in first 3 hours (Surviving Sepsis Campaign)
• Vasopressors (noradrenaline) if MAP <65 mmHg persists after fluid resuscitation
• Continuous cardiac monitoring; urinary catheter for hourly urine output monitoring

C - Investigations (draw before antibiotics)

• Blood: FBC (thrombocytopenia is a critical prognostic marker), U&E/creatinine, glucose, LFT, coagulation, blood cultures x2, serum lactate, CRP, procalcitonin
• Urine: MSU for MC&S (before antibiotics if possible)
• Serum HbA1c: confirms degree of glycaemic dyscontrol
• ABG/VBG with point-of-care lactate

D - Glycaemic Control

• Initiate insulin infusion for urgent blood glucose control (high glucose serves as a fermentable substrate for gas-forming bacteria - the direct driver of EPN)
• Target glucose 7-10 mmol/L; avoid hypoglycaemia

E - Imaging Confirmation

• CT KUB (non-contrast) has already been done here and is the gold standard - confirms diagnosis and allows classification
• Review urgently with urology, radiology, and intensive care

F - Urgent Specialist Referral

• Urology (source control within hours), ICU/HDU admission, nephrology input for AKI management
• Antibiotic administration within 1 hour of recognition of sepsis

PART 3 - Evidence-Based Antimicrobial Management (4 Marks)

Principles (Surviving Sepsis Campaign + IDSA/EAU Guidelines)

Empiric Regimen (Urosepsis with Source Control Required)

• Piperacillin-tazobactam 4.5 g IV q8h (extended infusion 4h preferred)
  OR
• Meropenem 1 g IV q8h OR Imipenem-cilastatin 500 mg IV q6h
  (Carbapenems preferred given: prior antibiotic exposure 1 week ago raising resistance risk, severely ill, diabetic, obstructed)

• Ceftriaxone 2 g IV OD or Cefepime 2 g IV q8h

• Gentamicin or amikacin as synergistic combination if haemodynamic instability/bacteraemia suspected (aminoglycoside + beta-lactam for 48-72 hours)
• Cover Enterococcus with ampicillin or vancomycin if Gram-positive cocci on urine Gram stain

De-escalation

• Review at 48-72 hours with culture and sensitivity results
• Narrow spectrum based on sensitivity: E. coli - trimethoprim-sulfamethoxazole or fluoroquinolone if susceptible; Klebsiella - 3rd-gen cephalosporin if non-ESBL
• Duration: 3-4 weeks of parenteral antibiotics are typically required for EPN, transitioning to oral when the patient is clinically improving and can tolerate oral intake - Campbell-Walsh-Wein, p. 55

Special Considerations

• ESBL-producing organisms: Carbapenems mandatory; consider local antibiogram (prior antibiotic use within 7 days is a key risk factor for ESBL/resistance)
• MRSA: Unlikely in UTI but add vancomycin if Gram-positive cocci confirmed
• Antifungal: Add fluconazole if Candida isolated in immunocompromised diabetic patient
• Therapeutic drug monitoring (TDM): Especially for aminoglycosides in AKI (this patient has oliguria - dose-adjust all renally cleared drugs)

PART 4 - Imaging, Radiological Classification, and Management Influence (3 Marks)

Role of Imaging

• Detects gas in parenchyma/perinephric space with near 100% sensitivity (plain X-ray detects gas in only ~50% of cases)
• Characterises extent: parenchymal destruction, fluid collections, perinephric extension, bilateral involvement
• Identifies the precipitating cause (obstructing calculus in this case)
• Enables classification to guide management
• Guides percutaneous drainage (PCD)

Huang and Tseng CT Classification (2000) - Currently Widely Used

How Classification Influences Management

• Class 1-2: Medical management alone or with PCD; 66% success rate with conservative approach
• Class 3A/3B with 0-1 risk factors: aggressive medical management + PCD can be attempted first
• Class 3A/3B with ≥2 of the following risk factors: emergency nephrectomy recommended:
  • Thrombocytopenia
  • Acute renal failure (serum creatinine >1.4 mg/dL)
  • Disturbance of consciousness
  • Shock
• This patient has at least 3-4 risk factors (drowsiness, oliguria/AKI, uncontrolled diabetes, prior failed antibiotics) - pointing strongly toward nephrectomy after initial resuscitation

PART 5 - Source Control Options Compared (4 Marks)

1. Medical Management Alone (Antibiotics + Supportive Care)

• Indication: Class 1, selected Class 2 patients with no obstruction and no risk factors
• Technique: IV broad-spectrum antibiotics, fluid resuscitation, glycaemic control, correction of electrolytes
• Advantages: Non-invasive; avoids surgical risk in high-risk patients
• Disadvantages: Mortality rate ~50% when used alone (vs. 13.5% with PCD); unacceptable as sole therapy in Class 3/4 or multi-risk-factor patients
• Not appropriate as sole management in this patient given Class 3B disease and multiple risk factors - Brenner and Rector's The Kidney, p. 1644

2. Percutaneous Catheter Drainage (PCD) + Ureteric Stenting

• Indication: Class 2, Class 3 (0-1 risk factors), Class 4 (solitary kidney), as a bridge in Class 3B before definitive nephrectomy
• Technique: Ultrasound- or CT-guided percutaneous nephrostomy (PCN) to drain the collecting system; ureteric stenting (retrograde or antegrade) to relieve the obstructing calculus
• Advantages: Minimally invasive; preserves renal function; success rate up to 66%; avoids GA in critically ill; the 2022 meta-analysis (PMID 35802159) confirmed minimally invasive intervention (PCN/ureteric stent) was associated with significantly decreased mortality (OR 0.47)
• Disadvantages: May not achieve adequate drainage if extensive parenchymal necrosis; requires repeat procedures; failure necessitates nephrectomy anyway; risk of septic shower on manipulation
• Role in this patient: PCN for urgent decompression of the obstructed infected system should be performed as an emergency alongside resuscitation. The obstructing calculus can be managed by ureteric stent or PCN. This may serve as a bridge to delayed elective nephrectomy if the patient stabilises.

3. Nephrectomy (Emergency or Elective)

• Indication: Class 3A/3B/4 with ≥2 risk factors; failure of PCD; rapidly deteriorating patient; destroyed non-functioning kidney; bilateral disease where one kidney is unsalvageable
• Technique: Open or laparoscopic nephrectomy; laparoscopic approach associated with less morbidity in stable patients; open preferred in emergency setting or when perinephric spread is extensive
• Advantages: Definitive source control; removes all infected tissue; mortality with emergency nephrectomy ~25% vs. 50% with medical management alone
• Disadvantages: Major surgery in a critically ill, septic, poorly controlled diabetic; risk of haemorrhage, prolonged ICU stay, and permanent loss of renal function; AKI from contralateral kidney impairment is a major concern
• Timing: If PCD fails or patient deteriorates within 24-48 hours of PCD, proceed to nephrectomy without further delay

Summary Recommendation for This Patient

PART 6 - Prognostic/Scoring Systems and Predictors of Poor Outcome (2 Marks)

Two Validated Scoring Systems

1. Huang and Tseng Risk Factor Score (2000) - EPN-specific: counts the number of the following poor prognostic markers present: thrombocytopenia, acute renal failure, altered consciousness, shock. ≥2 risk factors = emergency nephrectomy recommended. Shown to correlate with mortality outcomes in EPN.
2. SOFA Score / qSOFA (Sepsis-3 Definitions, 2016) - applicable to all septic patients including urosepsis. qSOFA (Respiratory rate ≥22, altered mentation, systolic BP <100) serves as a rapid bedside predictor of poor outcomes; full SOFA score guides ICU admission and prognosis. This patient scores high on both (drowsiness + oliguria suggesting organ dysfunction).

Five Predictors of Poor Outcome in EPN

1. Septic shock (systolic BP <90 mmHg) - OR 15.57 for mortality
2. Disturbance of consciousness (altered mental status, drowsiness, confusion) - OR 12.11
3. Thrombocytopenia (platelet count <60,000/μL or <100,000/μL) - OR 7.85
4. Acute renal failure (rising creatinine, oliguria/anuria) - OR 5.41
5. Huang-Tseng Class III-IV disease (bilateral or extensive extrarenal gas) - OR 2.4; also correlated: medical management alone (OR 2.04) - underscoring the necessity of procedural intervention

This patient has at least 3-4 of these poor prognostic factors at presentation (drowsiness, AKI/oliguria, prior failed antibiotics, Class 3B disease), placing her in the highest risk stratum and mandating aggressive combined medical-surgical management without delay.

Key References

• Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160:797-805
• Ngo XT et al. Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis. World J Surg. 2022 [PMID: 35802159]
• Wu SY et al. Emphysematous pyelonephritis: classification, management, and prognosis. Tzu Chi Med J. 2022 [PMID: 35912050]
• Campbell-Walsh-Wein Urology, 12th ed., Chapter 55
• Smith and Tanagho's General Urology, 19th ed., Chapter 14
• Brenner and Rector's The Kidney, Chapter on Emphysematous Pyelonephritis